10 fictional AI personas. Exploratory perspectives, not a survey of real customers. Methodology & limitations

Roy Kertzmann-Maggio

Roy Kertzmann-Maggio

NHS hematology research nurse coordinator

Full-depth AI personas

Why this persona fits the audience

Coordinates a four-person hematology research team at an NHS trust in Birmingham, screening referred lymphoma and myeloma patients against open protocols, keeping eligibility notes in spreadsheets, and using Antidote for some initial patient pre-screening.

  • Age: 45
  • Location: Birmingham, UK
  • Occupation: Research nurse coordinator
  • Income: GBP 58k/year
  • Education: BSc Adult Nursing, postgraduate research certificate
  • Company size: Large NHS Trust (approx. 2,000 staff)
  • Years in role: 6
“In this line of work, a single missed data point isn't just an error; it's a life that could have been saved, or worse, a patient exposed to unnecessary risk.”

Roy Kertzmann-Maggio has spent twenty years navigating the intersection of acute care and clinical research within the National Health Service. Born in the Black Country and raised in a working-class family that valued stability above all, Roy initially trained as an adult nurse, finding early fulfillment in bedside care. However, the systemic gaps he observed—patients missing out on cutting-edge treatments due to administrative inertia—pulled him toward research coordination six years ago. He holds a BSc in Adult Nursing and a postgraduate certificate in Research Methods, credentials that anchor his authority in a role demanding both medical expertise and bureaucratic fluency. Currently based at a major NHS trust in Birmingham, Roy serves as the linchpin for a specialized hematology unit. His domain is the complex world of lymphoma and myeloma trials, where the margin for error is nonexistent. His workflow is a testament to his conscientious nature: he meticulously coordinates a team of four, personally vetting every referral against a labyrinth of evolving protocols. While he utilizes 'Antidote' for initial pre-screening, the final arbiter of eligibility remains his own judgment, supported by a sprawling ecosystem of spreadsheets that he has built and maintained himself over years of incremental optimization. Roy operates with a steady, unflappable demeanor, a trait honed by decades of managing high-stakes environments. He is not driven by the allure of fame or rapid promotion but by a profound sense of duty to the public system. His income of £58,000 reflects his seniority and specialized skills, yet he lives modestly, channeling resources into his home and future security rather than conspicuous consumption. Recent decisions have focused on streamlining his team's workflow, though he remains skeptical of quick-fix solutions that lack robust validation. For Roy, the ideal outcome is not a flashy new interface, but a quieter, more reliable day where every patient record aligns perfectly with the latest scientific evidence, allowing him to focus entirely on the human element of the work.

Background & daily life

A day in their life

Roy wakes at 5:30 AM, checking his phone for any overnight alerts from the hospital server before brewing coffee. By 7:15 AM, he is commuting into Birmingham, listening to a podcast on recent breakthroughs in myeloma genetics. At 8:30 AM, he arrives at the trust, immediately reviewing the day's referral list on his tablet. The morning is a blur of ward rounds, where he explains trial options to confused families, followed by back-to-back meetings with the principal investigators regarding protocol amendments. Lunch is eaten quickly at his desk while updating the master eligibility spreadsheet. Afternoon sessions involve deep-dive data analysis, often wrestling with discrepancies between electronic health records and paper notes. He finishes around 5:30 PM, leaving the office only after ensuring all pending patient consents are filed correctly. Evenings are for decompressing with a walk or reading, strictly avoiding work emails until the weekend.

Lifestyle

Roy lives in a quiet, well-maintained semi in Solihull, just outside the city centre. His evenings are structured: he cooks simple meals, often preparing ingredients in advance to minimize stress after long shifts. He is an avid walker, frequently traversing the canals near his home or visiting the Jewellery Quarter on weekends to admire the industrial architecture. Financially, he is cautious but secure, prioritizing pension contributions and mortgage repayment over luxury spending. He rarely attends loud social gatherings, preferring intimate dinners with his wife or small group lunches with former nursing colleagues. Health is a non-negotiable priority; he maintains a strict sleep schedule and avoids alcohol except for occasional celebrations.

Work life

Roy's days are dominated by the rhythm of the hospital ward and the digital clutter of spreadsheet hell. He manages a tight-knit team of four nurses, overseeing their daily interactions with patients suffering from lymphoma and myeloma. A significant portion of his time is spent manually cross-referencing patient blood counts and genetic markers against complex protocol criteria, a task he currently handles via a patchwork of Excel sheets and the 'Antidote' AI tool for preliminary scans. The pressure is constant: ensuring no eligible patient misses a trial due to clerical error while maintaining rigorous clinical governance standards. He spends hours mediating between impatient consultants, administrative blockers, and anxious families, acting as the primary gatekeeper for research access.

Relationships

Roy's closest bond is with his wife, Elena, who works in local government planning; they share a mutual appreciation for order and community improvement. His two children, now university students, respect his work ethic but find his rigidity occasionally challenging to navigate socially. Professionally, he relies heavily on a small circle of trusted peers within the Midlands haematology network for advice on navigating NHS bureaucracy. He is not a 'networker' in the corporate sense, but his reputation for reliability precedes him, making him a go-to contact when complex ethical approvals stall.

How they decide

Roy approaches decisions through a lens of risk mitigation and evidence. He rarely acts on impulse or hearsay; instead, he requires concrete data, peer validation, and a clear understanding of the long-term implications before committing to a new process or tool. He values transparency and hates hidden costs or vague promises. If a solution appears too complex or lacks a clear audit trail, he will default to the status quo, even if it is inefficient, because the cost of failure in his field is too high.

How they sound

Roy speaks in a calm, measured baritone with a distinct West Midlands accent that softens the edges of his professional terminology. He avoids slang and hyperbole, preferring precise, factual language. In conversation, he pauses frequently to ensure accuracy, often correcting himself mid-sentence if a detail feels imprecise. He does not use emotional pleading or sales-style persuasion; instead, he frames arguments around logic, safety, and procedure. He is polite but firm, rarely raising his voice, and tends to end discussions with a definitive summary statement.

Personality traits

  • methodical
  • quietly authoritative
  • data-obsessed
  • pragmatic
  • meticulous
  • dislikes ambiguity
  • deeply empathetic but reserved
  • time-conscious
  • bureaucratically savvy
  • stoic under pressure

Goals

  • Reduce administrative burden on the research team by at least 20% annually
  • Increase patient recruitment rates for Phase II trials within the next fiscal year
  • Achieve full certification in advanced clinical data management
  • Mentor junior nurses into senior research coordination roles
  • Implement a seamless digital handover system between primary care and the trust

Problems & frictions

  • Fragmented data sources requiring manual reconciliation of patient history
  • Rapidly changing eligibility criteria across multiple competing trials
  • Difficulty accessing real-time updates on trial status from central databases
  • Limited budget for new software tools despite clear operational inefficiencies
  • High turnover of junior staff leading to inconsistent data entry quality
  • Balancing immediate patient care needs with long-term research recruitment targets

Values

  • protocol adherence
  • reliability
  • clarity
  • public service
  • patient safety

Interests

  • haematology
  • NHS workflow
  • clinical governance
  • trial setup
  • historical architecture of Birmingham

Media habits

  • British Medical Journal weekly digests
  • Hematology-specific podcasts during commute
  • Local council news updates
  • NHS England internal portals
  • Financial Times business section
  • Architectural review journals

Questions & answers

Roy Kertzmann-Maggio’s public research answers, newest questions first. Up to 10 per page.

  1. You land on https://www.clintrialfinder.info/ (ClinTrialFinder) for the first time. What's unclear, what makes you leave, and what would make you sign up?

    The initial impression is positive; the emphasis on ranking trials by evidence, not just eligibility, is intriguing. However, I'd need to understand the AI's backing – is it truly up-to-date with medical literature, or just correlating keywords? The workflow seems efficient, but I'm wary of anything that might bypass rigorous clinical governance. It's unclear if the results are exportable for our spreadsheets or if there's a cost involved for institutional use. If it genuinely streamlines our protocol screening and can be validated against our existing data without significant integration headaches, it might be worth exploring. I'd need to see a clear audit trail and understand the data privacy implications before signing up.
    View answer & full research →
Keep exploring

What would you ask next?

Test another angle with this panel, or create an audience for your own market.